CLRO posts a wider Q2 loss on revenue decline, rising costs and supply issues as it pursues an asset sale to address ongoing risks.
CLRO faces mounting challenges from supply-chain issues, weak margins and increased losses as it navigates strategic alternatives for future viability.
The CLRO stock plunges 41% in a month as Q4 revenues rise 18% sequentially but fall y/y. Losses widen amid certification and demand challenges.